01 July 2026
: Case report 
Starvation-Type Euglycemic Ketoacidosis After Unsupervised Tirzepatide Use in a Non-Obese, Non-Diabetic Woman
Unusual clinical course, Challenging differential diagnosis, Diagnostic / therapeutic accidents, Management of emergency care, Rare disease, Adverse events of drug therapy, Educational Purpose (only if useful for a systematic review or synthesis), Rare coexistence of disease or pathology
Eslam Elsayed Abdelshafey
ABCDEF 1, Khaled Sewify ABCDEF 1*, Atheer Almutairi ABC 1, Ragheb Elmessery ABCDEF 1, Sara Alotaishan DEF 2, Yasmin Youssuf Al-Gindan EF 2, Manal Ali Ahmad EF 3, Wael Gomaa ABCDEF 1
DOI: 10.12659/AJCR.952750
Am J Case Rep 2026; 27:e952750
Table 1 Initial laboratory test results at presentation.
| Test | Result | Unit | Reference range |
|---|---|---|---|
| WBC | 4.82 | ×10/L | 4–11 |
| HGB | 14.3 | g/dL | 12–16 |
| PLT | 342 | ×10/L | 140–450 |
| BUN | 1.2 | mmol/L | 2.5–6.7 |
| Creatinine | 55.4 | μmol/L | 50–98 |
| Sodium | 136 | mmol/L | 136–145 |
| Potassium | 4.3 | mmol/L | 3.5–5 |
| Magnesium | 0.76 | mmol/L | 0.66–1.07 |
| Chloride | 111 | mmol/L | 98–107 |
| CRP | 4.2 | mg/dL | <5 |
| Procalcitonin | 0.02 | ng/mL | <0.05 |
| Calcium | 2.3 | mmol/L | 2.1–2.55 |
| ALT | 12 | U/L | 7–40 |
| AST | 15 | U/L | 5–34 |
| ALP | 95 | U/L | 40–150 |
| Amylase | 38 | U/L | 25–125 |
| Lipase | 27 | U/L | 12–53 |
| Random glucose | 4.2 | mmol/L | 3.6–11 |
| Abbreviations: ALP, alkaline phosphatase; ALT, alanine aminotransferase; AST, aspartate aminotransferase; BUN, blood urea nitrogen; CRP, C-reactive protein; HGB, hemoglobin; PLT, platelet count; WBC, white blood cell count. | |||